
This Human IgG4 isotype control recombinant antibody has been tested against selected species' cells and tissues to assure minimal cross reactivity. Furthermore, this low endotoxin Human IgG4 antibody is suitable for in vivo applications. This Human IgG4 isotype control contains the S228P mutation
